Form 8-K - Current report:
SEC Accession No. 0001564590-21-014184
Filing Date
2021-03-18
Accepted
2021-03-18 16:40:20
Documents
3
Period of Report
2021-03-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abio-8k_20210318.htm 8-K 32104
2 EX-99.1 abio-ex991_6.htm EX-99.1 95410
3 GRAPHIC gbt2bt5q5bft000001.jpg GRAPHIC 14276
  Complete submission text file 0001564590-21-014184.txt   148662
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 21754872
SIC: 2835 In Vitro & In Vivo Diagnostic Substances